GLI
BIIB icon

Guardian Life Insurance’s Biogen BIIB Stock Holding History

Guardian Life Insurance’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-532
Closed -$158K – 60
2019
Q4 		$158K Sell
532
-8
-1% -$2.22K 0.04% 124
2019
Q3 		$126K Sell
540
-28
-5% -$6.52K 0.02% 159
2019
Q2 		$133K Hold
568
– – 0.02% 148
2019
Q1 		$134K Hold
568
– – 0.02% 138
2018
Q4 		$171K Hold
568
– – 0.03% 101
2018
Q3 		$201K Sell
568
-16
-3% -$5.51K 0.03% 93
2018
Q2 		$170K Buy
584
+98
+20% +$27.6K 0.03% 97
2018
Q1 		$133K Sell
486
-198
-29% -$61.5K 0.02% 110
2017
Q4 		$218K Buy
684
+204
+43% +$65.4K 0.05% 98
2017
Q3 		$150K Sell
480
-4
-0.8% -$1.18K 0.02% 99
2017
Q2 		$131K Sell
484
-355
-42% -$93.9K 0.02% 100
2017
Q1 		$229K Buy
839
+6
+0.7% +$1.7K 0.03% 102
2016
Q4 		$236K Buy
833
+13
+2% +$3.85K 0.03% 103
2016
Q3 		$257K Hold
820
– – 0.02% 122
2016
Q2 		$198K Sell
820
-5
-0.6% -$1.32K 0.02% 164
2016
Q1 		$215K Sell
825
-232
-22% -$61.3K 0.02% 149
2015
Q4 		$324K Sell
1,057
-319
-23% -$91.7K 0.03% 132
2015
Q3 		$402K Buy
1,376
+347
+34% +$115K 0.04% 131
2015
Q2 		$416K Hold
1,029
– – 0.04% 117
2015
Q1 		$434K Sell
1,029
-320
-24% -$126K 0.04% 122
2014
Q4 		$458K Hold
1,349
– – 0.05% 127
2014
Q3 		$446K Buy
1,349
+19
+1% +$6.26K 0.05% 122
2014
Q2 		$419K Hold
1,330
– – 0.04% 123
2014
Q1 		$407K Sell
1,330
-12
-0.9% -$3.81K 0.04% 133
2013
Q4 		$375K Sell
1,342
-1,506
-53% -$390K 0.03% 138
2013
Q3 		$686K Buy
2,848
+7
+0.2% +$1.57K 0.06% 140
2013
Q2 		$611K Buy
+2,841
New +$607K 0.06% 143

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Guardian Life Insurance's BIIB Position: Q1 2020 in Review

Guardian Life Insurance sold out of Biogen (BIIB) in Q1 2020, closing a stake of 532 shares — an estimated $158K sold.

Guardian Life Insurance first reported a position in BIIB in Q2 2013 and held it in 27 quarters. The position peaked at $686K in Q3 2013. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Guardian Life Insurance reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 532 Biogen shares in Q1 2020, an estimated $158K.
  • Guardian Life Insurance first reported a position in Biogen in Q2 2013 and held it in 27 quarters.
  • Guardian Life Insurance's Biogen position peaked at $686K in Q3 2013.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.